Quinolones: review of psychiatric and neurological adverse reactions
- PMID: 21585220
- DOI: 10.2165/11587280-000000000-00000
Quinolones: review of psychiatric and neurological adverse reactions
Abstract
Quinolones are a class of antibacterial agents for the treatment of several infectious diseases (e.g. urinary and respiratory tract infections). They are used worldwide due to their broad spectrum of activity, high bioavailability and good safety profile. The safety profile varies from quinolone to quinolone. The aim of this article was to review the neurological and psychiatric adverse drug reaction (ADR) profile of quinolones, using a literature search strategy designed to identify case reports and case series. A literature search using PubMed/MEDLINE (from inception to 31 October 2010) was performed to identify case reports and case series related to quinolone-associated neurological and psychiatric ADRs. The search was conducted in two phases: the first phase was the literature search and in the second phase relevant articles were identified through review of the references of the selected articles. Relevant articles were defined as articles referring to adverse events/reactions associated with the use of any quinolone. Abstracts referring to animal studies, clinical trials and observational studies were excluded. Identified case reports were analysed by age group, sex, active substances, dosage, concomitant medication, ambulatory or hospital-based event and seriousness, after Medical Dictionary for Regulatory Activities (MedDRA®) coding. From a total of 828 articles, 83 were identified as referring to nervous system and/or psychiatric disorders induced by quinolones. 145 individual case reports were extracted from the 83 articles. 40.7% of the individual case reports belonged to psychiatric disorders only, whereas 46.9% related to neurological disorders only. Eight (5.5%) individual case reports presented both neurological and psychiatric ADRs. Ciprofloxacin, ofloxacin and pefloxacin were the quinolones with more neurological and psychiatric ADRs reported in the literature. Ciprofloxacin has been extensively used worldwide, which may explain the higher number of reports, while for ofloxacin and pefloxacin, the number of reports may be over-representative. A total of 232 ADRs were identified from the selected articles, with 206 of these related to psychiatric and/or neurological ADRs. The other 26 were related to other body systems but were reported together with the reactions of interest. Mania, insomnia, acute psychosis and delirium were the most frequently reported psychiatric adverse events; grand mal convulsion, confusional state, convulsions and myoclonus were the most frequently reported neurological adverse events. Several aspects should be taken into account in the development of CNS adverse effects, such as the pharmacokinetics of quinolones, chemical structure and quinolone uptake in the brain. These events may affect not only susceptible patients but also 'healthy' patients.
Similar articles
-
Quinolone-induced psychosis: an updated review.Actas Esp Psiquiatr. 2020 May;48(3):126-37. Epub 2020 May 1. Actas Esp Psiquiatr. 2020. PMID: 32905605 Review.
-
[The history of the development and changes of quinolone antibacterial agents].Yakushigaku Zasshi. 2003;38(2):161-79. Yakushigaku Zasshi. 2003. PMID: 15143768 Japanese.
-
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System.Front Pharmacol. 2020 Apr 15;11:428. doi: 10.3389/fphar.2020.00428. eCollection 2020. Front Pharmacol. 2020. PMID: 32351386 Free PMC article.
-
Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.Drug Saf. 2008;31(12):1115-23. doi: 10.2165/0002018-200831120-00007. Drug Saf. 2008. PMID: 19026028
-
Safety issues and drug-drug interactions with commonly used quinolones.Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25-39. doi: 10.1517/17425255.2014.970166. Epub 2014 Nov 26. Expert Opin Drug Metab Toxicol. 2015. PMID: 25423877 Review.
Cited by
-
Levofloxacin-induced acute anxiety and insomnia.J Neurosci Rural Pract. 2012 May;3(2):212-4. doi: 10.4103/0976-3147.98256. J Neurosci Rural Pract. 2012. PMID: 22865986 Free PMC article.
-
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.J Affect Disord. 2020 Dec 1;277:337-340. doi: 10.1016/j.jad.2020.08.031. Epub 2020 Aug 20. J Affect Disord. 2020. PMID: 32858315 Free PMC article.
-
Ciprofloxacin-induced psychosis.Antimicrob Agents Chemother. 2013 Aug;57(8):4079. doi: 10.1128/AAC.00672-13. Epub 2013 May 13. Antimicrob Agents Chemother. 2013. PMID: 23669392 Free PMC article. No abstract available.
-
Pitfalls associated with the diagnosis of herpes simplex encephalitis.J Neurosci Rural Pract. 2013 Apr;4(2):176-9. doi: 10.4103/0976-3147.112756. J Neurosci Rural Pract. 2013. PMID: 23914095 Free PMC article.
-
Levofloxacin induced delirium with psychotic features in a young patient.Med J Armed Forces India. 2013 Oct;69(4):404-5. doi: 10.1016/j.mjafi.2012.10.001. Epub 2012 Dec 29. Med J Armed Forces India. 2013. PMID: 24600154 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials